Nasdaq

Alpha Tau Medical Achieves MDSAP Certification for Jerusalem Manufacturing Facility

Alpha Tau Medical Ltd. announced that it has achieved Medical Device Single Audit Program (MDSAP) certification for its manufacturing facility in Jerusalem, which is a key step in ensuring quality, ...

Alpha Tau to Participate in May Investor Conferences

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment o ...
Nasdaq

Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at ...

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources.
Yahoo Finance

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Investing

Alpha Tau reports disease control in pancreatic cancer trial

JERUSALEM - Alpha Tau Medical Ltd. (NASDAQ:DRTS) presented pooled results from two early-stage clinical trials of its Alpha DaRT treatment in pancreatic ductal adenocarcinoma at Digestive Disease Week ...

Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies

Abstract accepted at the American Society of Clinical Oncology (ASCO) Annual Meeting - the world’s largest and most prestigious medical ...